Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Nifedipine 20 mg SR tablet
Therapeutic Category
Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Nifenorm 20 Tablet contains Nifedipine 20 mg SR, a calcium channel blocker (CCB) used to treat hypertension and angina pectoris. Nifedipine works by inhibiting the influx of calcium ions into vascular smooth muscle and cardiac muscle cells, resulting in relaxation of blood vessels and improved blood flow. The sustained-release (SR) formulation provides a gradual and prolonged effect, maintaining stable blood pressure control throughout the day while reducing the risk of sudden drops in blood pressure. Nifenorm 20 helps reduce the workload on the heart, lowers the risk of heart attack and stroke, and improves oxygen supply to the heart muscle in patients with angina. The 20 mg SR dose is commonly used as part of long-term therapy for hypertension or chronic stable angina, either as monotherapy or in combination with other antihypertensives.
Common side effects include headache, flushing, dizziness, fatigue, and mild swelling of the ankles (peripheral edema). Other possible effects include palpitations, nausea, or constipation. Rarely, it may cause hypotension, gingival hyperplasia (gum overgrowth), or an exaggerated heart rate increase. Most side effects are dose-related and tend to diminish with continued therapy or dose adjustment.
Nifenorm 20 Tablet is indicated for the management of essential hypertension and chronic stable angina pectoris. It may also be used in certain cases of vasospastic (Prinzmetal’s) angina and as an adjunct in hypertensive emergencies (under medical supervision).
Nifenorm 20 Tablet should be taken exactly as prescribed. Do not chew or crush the sustained-release tablet as it is designed for gradual drug release. It is contraindicated in patients with severe aortic stenosis, cardiogenic shock, or hypersensitivity to Nifedipine. Caution is advised in patients with heart failure, liver dysfunction, or low blood pressure. The medicine should not be stopped abruptly, as sudden withdrawal may worsen angina or cause a rebound increase in blood pressure. It is not recommended during pregnancy unless absolutely necessary and should be used with caution during breastfeeding. Avoid consuming grapefruit juice while taking Nifenorm, as it can interfere with the drug's metabolism and increase side effects.
Store Nifenorm 20 Tablet in a cool, dry place away from direct sunlight and moisture. Keep the medication at a temperature below 30°C and out of reach of children. Do not use the tablet beyond the expiry date printed on the packaging.
Composition : Nifedipine 30 mg SR tablet
Composition : Olmesartan Medoxomil (40mg) tablet
Composition : Olmesartan 20 mg + Hydrochlorothiazide 12.50 mg tablet
Composition : Olmesartan 40 mg + hydrochlorothiazide 12.50 mg tablet
Composition : Eplerenone (50mg) tablet
Composition : Prasugrel 10 mg Tablets
Composition : Aspirin 75mg + Rosuvastatin 20mg + Clopidogrel 150mg Tablet
Composition : Rosuvastatin 10mg + Clopidogrel 75mg Capsule
Composition : Rosuvastatin 5mg + fenofibrate 160 mg tablet
Composition : Rosuvastatin Calcium IP eq. to Rosuvastatin (as pellets) 20 mg. + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg. Excipients q.s.
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Nifedipine 20 mg SR Tablet is a sustained-release calcium channel blocker used for the management of hypertension (high blood pressure), chronic stable angina, and other cardiovascular disorders. The sustained-release formulation provides prolonged blood pressure control and improved patient compliance. This product is widely prescribed in the cardiology and cardiovascular care segment, making it a valuable addition for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand from cardiologists, physicians, and healthcare providers. With the increasing prevalence of hypertension and cardiovascular diseases, Nifedipine 20 mg SR Tablet offers steady prescription demand, repeat purchases, and long-term business opportunities.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities in the cardiology and cardiovascular care segment with monopoly rights, quality-assured manufacturing standards, attractive promotional support, and reliable product supply for distributors and franchise partners.
Wholesalers and distributors benefit from strong prescription demand, long-term patient usage, growing awareness of cardiovascular health, and continuous requirements from hospitals and clinics, making this product a profitable and sustainable addition to their pharmaceutical portfolio when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in cardiology and antihypertensive formulations can contact Cafoli Lifecare to discuss product availability, pricing structure, promotional support, and PCD pharma franchise opportunities in the cardiovascular care segment.